Chem Rx Corporation Postpones Conference Call to Review Full Year 2007 Financial Results

LONG BEACH, N.Y., March 31 /PRNewswire-FirstCall/ -- Chem Rx Corporation (BULLETIN BOARD: PMQC, PMQCU, PMQCW) , a leading provider of institutional pharmacy services, announced today that it has postponed its conference call to review 2007 financial results and discuss 2008 outlook that was originally scheduled for April 1, 2008 at 8:30 a.m. ET. Additional details about the timing of the 2007 financial results press release and corresponding conference call will be forthcoming shortly.

About Chem Rx Corporation

Founded more than 40 years ago, Chem Rx Corporation is a leading provider of institutional pharmacy services in the New York City metropolitan area, as well as parts of New Jersey, upstate New York, and Pennsylvania. Chem Rx's client base includes skilled nursing facilities and a wide range of other long-term care facilities. Through its services, Chem Rx provides more than 65,000 institutional residents with prescription and non-prescription drugs, intravenous medications, durable medical equipment items and surgical supplies. Chem Rx's website address is www.chemrx.net.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are based upon the current beliefs and expectations of Chem Rx's management and are subject to risks and uncertainties that could cause actual results to differ from the forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: compliance with government regulations; changes in legislation or regulatory environments; requirements or changes adversely affecting the health care industry, including changes in Medicare reimbursement policies; fluctuations in customer demand; management of rapid growth; intensity of competition; timing, approval and market acceptance of new product introductions and institutional pharmacy locations; general economic conditions; geopolitical events and regulatory changes, as well as other relevant risks detailed in Chem Rx's filings with the Securities and Exchange Commission. The information set forth herein should be read in light of such risks. Chem Rx Corporation does not assume any obligation to update the information contained in this press release.

Contacts:
Steven C. Silva
President and Chief Operating Officer
Chem Rx Corporation
516-889-8770

The Ruth Group
Investor Relations
Stephanie Carrington / Jared Hoffman
(646) 536-7017 / 7013
scarrington@theruthgroup.comjhoffman@theruthgroup.com


Source: Chem Rx Corporation

CONTACT: Steven C. Silva, President and Chief Operating Officer of Chem
Rx Corporation, +1-516-889-8770; Stephanie Carrington, +1-646-536-7017,
scarrington@theruthgroup.com, or Jared Hoffman, +1-646-536-7013,
jhoffman@theruthgroup.com, both of The Ruth Group Investor Relations for Chem
Rx Corporation

Web site: http://www.chemrx.net/


2008-03-31 22:58:12 0324146 PRNEWSWIRE

Legal Disclaimer: We are not responsible for the content of the news. Please, contact each company regarding their message.

HOME || Press Release Archive || © Leigh Media Corporation || Terms of Use || Privacy Policy || Publish Your Press Release Here

Market Segmentation Starts Here || Free Advertising

Search Term: